Patrick Donnelly
Stock Analyst at Citigroup
(3.72)
# 765
Out of 5,106 analysts
356
Total ratings
52.36%
Success rate
6.47%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Buy | $100 → $135 | $101.34 | +33.21% | 11 | Dec 11, 2025 | |
| TXG 10x Genomics | Downgrades: Neutral | $18 | $16.94 | +6.26% | 13 | Dec 11, 2025 | |
| TMO Thermo Fisher Scientific | Upgrades: Buy | $580 → $660 | $575.70 | +14.64% | 21 | Dec 11, 2025 | |
| QGEN Qiagen | Downgrades: Neutral | $55 → $50 | $46.05 | +8.58% | 14 | Dec 11, 2025 | |
| FTRE Fortrea Holdings | Upgrades: Buy | $12 → $21 | $17.69 | +18.71% | 5 | Dec 11, 2025 | |
| A Agilent Technologies | Maintains: Buy | $165 → $185 | $138.52 | +33.55% | 27 | Nov 25, 2025 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,600 → $1,700 | $1,412.41 | +20.36% | 15 | Nov 10, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $350 → $375 | $304.85 | +23.01% | 17 | Oct 30, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $350 → $375 | $303.27 | +23.65% | 17 | Oct 30, 2025 | |
| IQV IQVIA Holdings | Maintains: Neutral | $200 → $230 | $224.37 | +2.51% | 13 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $40 → $33 | $29.81 | +10.70% | 6 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $225 → $200 | $179.14 | +11.64% | 10 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $55 → $70 | $58.96 | +18.72% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $28.46 | +47.58% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $40 → $38 | $48.77 | -22.08% | 17 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 → $200 | $203.02 | -1.49% | 21 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $60 → $80 | $74.91 | +6.79% | 15 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $85 → $80 | $137.60 | -41.86% | 17 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $22 → $18 | $11.24 | +60.14% | 8 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $185 | $176.34 | +4.91% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $228.01 | +16.22% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $20 | $17.28 | +15.74% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $101.82 | -26.34% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $20.53 | +36.39% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $97.77 | +48.31% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $384.14 | -21.90% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $2.41 | +273.44% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $3.60 | -23.61% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $255.06 | +1.94% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $8.72 | -31.19% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $6.76 | +373.37% | 2 | Nov 30, 2018 |
Guardant Health
Dec 11, 2025
Maintains: Buy
Price Target: $100 → $135
Current: $101.34
Upside: +33.21%
10x Genomics
Dec 11, 2025
Downgrades: Neutral
Price Target: $18
Current: $16.94
Upside: +6.26%
Thermo Fisher Scientific
Dec 11, 2025
Upgrades: Buy
Price Target: $580 → $660
Current: $575.70
Upside: +14.64%
Qiagen
Dec 11, 2025
Downgrades: Neutral
Price Target: $55 → $50
Current: $46.05
Upside: +8.58%
Fortrea Holdings
Dec 11, 2025
Upgrades: Buy
Price Target: $12 → $21
Current: $17.69
Upside: +18.71%
Agilent Technologies
Nov 25, 2025
Maintains: Buy
Price Target: $165 → $185
Current: $138.52
Upside: +33.55%
Mettler-Toledo International
Nov 10, 2025
Maintains: Buy
Price Target: $1,600 → $1,700
Current: $1,412.41
Upside: +20.36%
Bio-Rad Laboratories
Oct 30, 2025
Maintains: Buy
Price Target: $350 → $375
Current: $304.85
Upside: +23.01%
Bio-Rad Laboratories
Oct 30, 2025
Maintains: Buy
Price Target: $350 → $375
Current: $303.27
Upside: +23.65%
IQVIA Holdings
Oct 29, 2025
Maintains: Neutral
Price Target: $200 → $230
Current: $224.37
Upside: +2.51%
Oct 7, 2025
Downgrades: Neutral
Price Target: $40 → $33
Current: $29.81
Upside: +10.70%
Aug 21, 2025
Downgrades: Neutral
Price Target: $225 → $200
Current: $179.14
Upside: +11.64%
Aug 21, 2025
Upgrades: Buy
Price Target: $55 → $70
Current: $58.96
Upside: +18.72%
Aug 13, 2025
Maintains: Buy
Price Target: $34 → $42
Current: $28.46
Upside: +47.58%
Aug 4, 2025
Maintains: Neutral
Price Target: $40 → $38
Current: $48.77
Upside: -22.08%
Jul 9, 2025
Upgrades: Buy
Price Target: $150 → $200
Current: $203.02
Upside: -1.49%
Jul 9, 2025
Upgrades: Buy
Price Target: $60 → $80
Current: $74.91
Upside: +6.79%
Jul 9, 2025
Downgrades: Sell
Price Target: $85 → $80
Current: $137.60
Upside: -41.86%
Mar 4, 2025
Maintains: Neutral
Price Target: $22 → $18
Current: $11.24
Upside: +60.14%
Mar 4, 2025
Downgrades: Neutral
Price Target: $185
Current: $176.34
Upside: +4.91%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $228.01
Upside: +16.22%
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $17.28
Upside: +15.74%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $101.82
Upside: -26.34%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $20.53
Upside: +36.39%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $97.77
Upside: +48.31%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $384.14
Upside: -21.90%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $2.41
Upside: +273.44%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $3.60
Upside: -23.61%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $255.06
Upside: +1.94%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $8.72
Upside: -31.19%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $6.76
Upside: +373.37%